Viewing Study NCT06177067


Ignite Creation Date: 2025-12-25 @ 12:28 AM
Ignite Modification Date: 2026-03-11 @ 11:21 AM
Study NCT ID: NCT06177067
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2023-12-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
Sponsor: St. Jude Children's Research Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module